Table 2 Mammograms enhanced the preoperative prediction of lymph node metastasis across all datasets
Set | Model modality | ROC AUC ± SD | Improvement CI (95%) | p value |
|---|---|---|---|---|
Development set (site 1, N = 688, Double CV) | PreopClinic | 0.616 ± 0.023 | – | – |
PreopClinic + FullMammo | 0.639 ± 0.023 | −0.006–0.050 | 0.119 | |
PreopClinic + ROIMammo | 0.668 ± 0.022 | 0.018–0.083 | 0.002 | |
PreopClinic + Tsize&Multifoc | 0.718 ± 0.021 | 0.063–0.140 | <0.001 | |
Development set (site 2, N = 259, Double CV) | PreopClinic | 0.687 ± 0.039 | – | – |
PreopClinic + FullMammo | 0.748 ± 0.035 | 0.006–0.108 | 0.021 | |
PreopClinic + ROIMammo | 0.748 ± 0.035 | −0.002–0.119 | 0.071 | |
PreopClinic + Tsize&Multifoc | 0.747 ± 0.032 | −0.005–0.119 | 0.077 | |
Independent test (site 2, N = 109) | PreopClinic | 0.690 ± 0.063 | – | – |
PreopClinic + FullMammo | 0.774 ± 0.057 | 0.001–0.154 | 0.037 | |
PreopClinic + ROIMammo | 0.757 ± 0.060 | −0.021–0.143 | 0.142 | |
PreopClinic + Tsize&Multifoc | 0.747 ± 0.054 | −0.058–0.159 | 0.300 |